Skip to main content
SpringerLink
Log in

Dissemination and Implementation Science

  • Chapter
  • First Online:
Communicating about Risks and Safe Use of Medicines

Abstract

The dissemination and implementation of health interventions is the active and targeted distribution of information and intervention materials to a specific public health, healthcare professional or patient audience with the goal of transferring knowledge and/or promoting changes in health attitudes and behaviours. In this chapter, we present key tenets of effective health dissemination and implementation in the context of medicinal product risk minimisation and communication. We review best practices and recommendations from dissemination and implementation (D&I) science and discuss their application to risk minimisation programme design, implementation and evaluation stages. To illustrate these concepts, we examine the evolution of the valproate risk minimisation programme in Europe.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 89.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 119.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  • Agency for Healthcare Research and Quality. Health Literacy Measurement Tools (Revised) [updated February 2016]. Available from: https://www.ahrq.gov/health-literacy/quality-resources/tools/literacy/index.html

  • Albright K, Gechter K, Kempe A (2013) Importance of mixed methods in pragmatic trials and dissemination and implementation research. Acad Pediatr 13(5):400–407

    Article  PubMed  Google Scholar 

  • Alrwisan AA, Wei YJ, Brumback BA, Antonelli PJ, Winterstein AG (2019) Concomitant use of quinolones and stimulants and the risk of adverse cardiovascular symptoms: a retrospective cohort study. Pharmacotherapy

    Google Scholar 

  • Ancker JS, Senathirajah Y, Kukafka R, Starren JB (2006) Design features of graphs in health risk communication: a systematic review. J Am Med Inform Assoc 13(6):608–618

    Article  PubMed  PubMed Central  Google Scholar 

  • ASQ (2015) ASQ/ANSI/ISO 9000:2015: quality management systems - fundamentals and vocabulary. American Society for Quality, Milwaukee

    Google Scholar 

  • BBC News (2017) New evidence in France of harm from epilepsy drug valproate. April 20, 2017

    Google Scholar 

  • Bian J, Chen B, Hershman DL, Marks N, Norris L, Schulz R et al (2017) Effects of the US food and drug administration boxed warning of erythropoietin-stimulating agents on utilization and adverse outcome. J Clin Oncol 35(17):1945–1951

    Article  PubMed  PubMed Central  Google Scholar 

  • Birken SA, Powell BJ, Presseau J, Kirk MA, Lorencatto F, Gould NJ et al (2017) Combined use of the Consolidated Framework for Implementation Research (CFIR) and the Theoretical Domains Framework (TDF): a systematic review. Implement Sci 12(1):2

    Article  PubMed  PubMed Central  Google Scholar 

  • Brewer NT (2011) Goals. In: Fischoff B, Brewer NT, Downs JS (eds) Communicating risks and benefits: an evidence-based user’s guide. Food and Drug Administration, U.S. Department of Health and Human Services, Silver Spring, pp 3–10

    Google Scholar 

  • Brewer SE, Campagna EJ, Morrato EH (2019) Advancing regulatory science and assessment of FDA REMS programs: a mixed-methods evaluation examining physician survey response. J Clin Transl Sci 3(4):199–209

    Article  PubMed  PubMed Central  Google Scholar 

  • Brown P, Bahri P (2019) ‘Engagement’ of patients and healthcare professionals in regulatory pharmacovigilance: establishing a conceptual and methodological framework. Eur J Clin Pharmacol 75(9):1181–1192

    Article  CAS  PubMed  Google Scholar 

  • Brownson RC, Jacobs JA, Tabak RG, Hoehner CM, Stamatakis KA (2013) Designing for dissemination among public health researchers: findings from a national survey in the United States. Am J Public Health 103(9):1693–1699

    Article  PubMed  PubMed Central  Google Scholar 

  • Brownson RC, Colditz GA, Proctor EK (eds) (2017) Dissemination and implementation research in health: translating science to practice, 2nd edn. Oxford University Press, New York

    Google Scholar 

  • Brownson RC, Fielding JE, Green LW (2018) Building capacity for evidence-based public health: reconciling the pulls of practice and the push of research. Annu Rev Public Health 39:27–53

    Article  PubMed  Google Scholar 

  • Center for Drug Evaluation and Research, Center for Biologics Evaluation and Research (2011) In: US Department of Health and Human Services (ed) Guidance medication guides -- distribution requirements and inclusion in Risk Evaluation and Mitigation Strategies (REMS)

    Google Scholar 

  • Center for Drug Evaluation and Research, Center for Biologics Evaluation and Research (2019a) In: US Department of Health and Human Services (ed) REMS assessment: planning and reporting. Guidance for industry (draft guidance). Food and Drug Administration, Silver Spring

    Google Scholar 

  • Center for Drug Evaluation and Research, Center for Biologics Evaluation and Research (2019b) In: US Department of Health and Human Services (ed) Survey methodologies to assess REMS goals that relate to knowledge. Guidance to industry (draft guidance)

    Google Scholar 

  • Centers for Disease Control and Prevention (2018) Writing smart objectives. Available from: https://www.cdc.gov/healthyyouth/evaluation/pdf/brief3b.pdf

  • Chambers DA (2019) Sharpening our focus on designing for dissemination: lessons from the SPRINT program and potential next steps for the field. Transl Behav Med

    Google Scholar 

  • Chambers DA, Norton WE (2016) The adaptome: advancing the science of intervention adaptation. Am J Prev Med 51(4 Suppl 2):S124–S131

    Article  PubMed  PubMed Central  Google Scholar 

  • Chan HW, Russell AM, Smith MY (2018) What is the quality of drug safety information for patients: an analysis of REMS educational materials. Pharmacoepidemiol Drug Saf 27(9):969–978

    Article  PubMed  PubMed Central  Google Scholar 

  • Committee on Risk Perception and Communication (1989) Improving risk communication. The National Academies Press, Washington, D.C.

    Google Scholar 

  • Damschroder LJ, Aron DC, Keith RE, Kirsh SR, Alexander JA, Lowery JC (2009) Fostering implementation of health services research findings into practice: a consolidated framework for advancing implementation science. Implement Sci 4:50

    Article  PubMed  PubMed Central  Google Scholar 

  • Dearing JW, Cox JG (2018) Diffusion of innovations theory, principles, and practice. Health Aff (Millwood) 37(2):183–190

    Article  Google Scholar 

  • Dearing JW, Smith DK, Larson RS, Estabrooks CA (2013) Designing for diffusion of a biomedical intervention. Am J Prev Med 44(1 Suppl 2):S70–S76

    Article  PubMed  Google Scholar 

  • European Medicines Agency. PRAC recommends strengthening the restrictions on the use of valproate in women and girls [press release]. October 10, 2014

    Google Scholar 

  • European Medicines Agency and Heads of Medicines Agencies (2015a) Guideline on Good Pharmacovigilance Practices (GVP) Module XVI Addendum I - educational materials

    Google Scholar 

  • European Medicines Agency and Heads of Medicines Agencies (2015b) Guideline on Good Pharmacovigilance Practices (GVP) Module XVI - risk minimisation measures: selection of tools and effectiveness indicators (Rev 2)

    Google Scholar 

  • European Medicines Agency and Heads of Medicines Agencies (2017a) Guideline on Good Pharmacovigilance Practices (GVP) Module V - risk management systems (Rev 2)

    Google Scholar 

  • European Medicines Agency and Heads of Medicines Agencies (2017b) Guideline on Good Pharmacovigilance Practices (GVP) Module XV - safety communication (Rev 1)

    Google Scholar 

  • European Medicines Agency and Heads of Medicines Agencies (2017c) Guideline on Good Pharmacovigilance Practices (GVP) Annex I - definitions (Rev 4)

    Google Scholar 

  • European Medicines Agency and Heads of Medicines Agencies (2017d) Summary of the EMA public hearing on valproate in pregnancy

    Google Scholar 

  • European Medicines Agency and Heads of Medicines Agencies (2018a) New measures to avoid valproate exposure in pregnancy endorsed. Member State representatives agree new restrictions and pregnancy prevention programme

    Google Scholar 

  • European Medicines Agency and Heads of Medicines Agencies (2018b) Public hearing on valproate: written interventions

    Google Scholar 

  • Field TS, Cadoret CA, Brown ML, Ford M, Greene SM, Hill D et al (2002) Surveying physicians: do components of the “Total Design Approach” to optimizing survey response rates apply to physicians? Med Care 40(7):596–605

    Article  PubMed  Google Scholar 

  • Fischoff B, Brewer NT, Downs JS (eds) (2011) Communicating risks and benefits: an evidence-based user’s guide. Food and Drug Administration, U.S. Department of Health and Human Services, Silver Spring

    Google Scholar 

  • Gellad ZF, Day TE (2016) What is value stream mapping, and how can it help my practice? Am J Gastroenterol 111(4):447–448

    Article  PubMed  PubMed Central  Google Scholar 

  • Glasgow RE, Chambers D (2012) Developing robust, sustainable, implementation systems using rigorous, rapid and relevant science. Clin Transl Sci 5(1):48–55

    Article  PubMed  PubMed Central  Google Scholar 

  • Glasgow RE, Vinson C, Chambers D, Khoury MJ, Kaplan RM, Hunter C (2012) National Institutes of Health approaches to dissemination and implementation science: current and future directions. Am J Public Health 102(7):1274–1281

    Article  PubMed  PubMed Central  Google Scholar 

  • Glasgow RE, Harden SM, Gaglio B, Rabin B, Smith ML, Porter GC et al (2019) RE-AIM planning and evaluation framework: adapting to new science and practice with a 20-year review. Front Public Health 7:64

    Article  PubMed  PubMed Central  Google Scholar 

  • Glasziou P, Haynes B (2005) The paths from research to improved health outcomes. ACP J Club 142(2):A8–A10

    PubMed  Google Scholar 

  • Green L, Kreuter M (2005) Health program planning: an educational and ecological approach, 4th edn. McGraw Hill, New York

    Google Scholar 

  • Green LW, Ottoson JM, Garcia C, Hiatt RA (2009) Diffusion theory and knowledge dissemination, utilization, and integration in public health. Annu Rev Public Health 30:151–174

    Article  PubMed  Google Scholar 

  • Green CA, Duan N, Gibbons RD, Hoagwood KE, Palinkas LA, Wisdom JP (2015) Approaches to mixed methods dissemination and implementation research: methods, strengths, caveats, and opportunities. Adm Policy Ment Health 42(5):508–523

    Article  PubMed  PubMed Central  Google Scholar 

  • Handley MA, Lyles CR, McCulloch C, Cattamanchi A (2018) Selecting and improving quasi-experimental designs in effectiveness and implementation research. Annu Rev Public Health 39:5–25

    Article  PubMed  PubMed Central  Google Scholar 

  • Harel Z, Silver SA, McQuillan RF, Weizman AV, Thomas A, Chertow GM et al (2016) How to diagnose solutions to a quality of care problem. Clin J Am Soc Nephrol 11(5):901–907

    Article  PubMed  PubMed Central  Google Scholar 

  • Harris JR, Cheadle A, Hannon PA, Forehand M, Lichiello P, Mahoney E et al (2012) A framework for disseminating evidence-based health promotion practices. Prev Chronic Dis 9:E22

    Article  PubMed  Google Scholar 

  • Ho K, Peter Wall Workshop P (2014) Harnessing the social web for health and wellness: issues for research and knowledge translation. J Med Internet Res 16(2):e34

    Article  PubMed  PubMed Central  Google Scholar 

  • Huebschmann AG, Leavitt IM, Glasgow RE (2019) Making health research matter: a call to increase attention to external validity. Annu Rev Public Health 40:45–63

    Article  PubMed  Google Scholar 

  • Institute of Medicine Committee on Quality of Health Care in America (2001) Crossing the quality chasm: a new health system for the 21st century. National Academies Press (US), Washington (DC)

    Google Scholar 

  • Issen L, Woodcock T, McNicholas C, Lennox L, Reed JE (2018) Criteria for evaluating programme theory diagrams in quality improvement initiatives: a structured method for appraisal. Int J Qual Health Care 30(7):508–513

    Article  PubMed  PubMed Central  Google Scholar 

  • Keith RE, Crosson JC, O’Malley AS, Cromp D, Taylor EF (2017) Using the Consolidated Framework for Implementation Research (CFIR) to produce actionable findings: a rapid-cycle evaluation approach to improving implementation. Implement Sci 12(1):15

    Article  PubMed  PubMed Central  Google Scholar 

  • Knox C, Hampp C, Willy M, Winterstein AG, Dal Pan G (2015) Patient understanding of drug risks: an evaluation of medication guide assessments. Pharmacoepidemiol Drug Saf 24(5):518–525

    Article  PubMed  PubMed Central  Google Scholar 

  • Kreuter MW, Wang ML (2015) From evidence to impact: recommendations for a dissemination support system. New Dir Child Adolesc Dev 2015(149):11–23

    Article  PubMed  PubMed Central  Google Scholar 

  • Leong Wai Yeen J, Salek S, Walker S (2014) Strategy for communicating benefit-risk decisions: a comparison of regulatory agencies’ publicly available documents. Front Pharmacol 5:269

    Article  PubMed  PubMed Central  Google Scholar 

  • McGettigan P, Alonso Olmo C, Plueschke K, Castillon M, Nogueras Zondag D, Bahri P et al (2019) Patient registries: an underused resource for medicines evaluation: operational proposals for increasing the use of patient registries in regulatory assessments. Drug Saf

    Google Scholar 

  • Morrato EH (2018) Social science theory as a framework for designing and evaluating pharmaceutical risk mitigation dissemination and implementation strategies. In: Sietsema WK, Sprafka JM (eds) Risk management principles for devices and pharmaceuticals: global perspectives on the benefit: risk assessment of medicinal products, 2nd edn. Regulatory Affairs Professional Society, Rockville

    Google Scholar 

  • Morrato EH, Libby AM, Orton HD, Degruy FV 3rd, Brent DA, Allen R et al (2008) Frequency of provider contact after FDA advisory on risk of pediatric suicidality with SSRIs. Am J Psychiatry 165(1):42–50

    Article  PubMed  Google Scholar 

  • Morrato EH, Brewer SE, Campagna EJ, Dickinson LM, Thomas DS, Druss BG et al (2016) Glucose testing for adults receiving Medicaid and antipsychotics: a population-based prescriber survey on behaviors, attitudes, and barriers. Psychiatr Serv 67(7):798–802

    Article  PubMed  PubMed Central  Google Scholar 

  • Morris JK, Garne E, Loane M, Addor MC, Barisic I, Bianchi F et al (2018) Prevalence of valproate syndrome in Europe from 2005 to 2014: a registry based multi-centre study. Eur J Med Genet 61(9):479–482

    Article  PubMed  Google Scholar 

  • Muhlbacher AC, Juhnke C, Beyer AR, Garner S (2016) Patient-focused benefit-risk analysis to inform regulatory decisions: the European Union perspective. Value Health 19(6):734–740

    Article  PubMed  Google Scholar 

  • Nilsen P (2015) Making sense of implementation theories, models and frameworks. Implement Sci 10(1)

    Google Scholar 

  • Nilsen P, Bernhardsson S (2019) Context matters in implementation science: a scoping review of determinant frameworks that describe contextual determinants for implementation outcomes. BMC Health Serv Res 19(1):189

    Article  PubMed  PubMed Central  Google Scholar 

  • Office of the Associate Director for Communications (2016) In: U.S. Department of Health and Human Services (ed) Everyday words for public health communication

    Google Scholar 

  • Prieto L, Spooner A, Hidalgo-Simon A, Rubino A, Kurz X, Arlett P (2012) Evaluation of the effectiveness of risk minimization measures. Pharmacoepidemiol Drug Saf 21(8):896–899

    Article  PubMed  Google Scholar 

  • Proctor EK, Powell BJ, Baumann AA, Hamilton AM, Santens RL (2012) Writing implementation research grant proposals: ten key ingredients. Implement Sci 7(1):96

    Article  PubMed  PubMed Central  Google Scholar 

  • Rabin BA, Brownson RC (2017) Terminology for dissemination and implementation research. In: Brownson RC, Colditz GA, Proctor EK (eds) Dissemination and implementation research in health: translating science to practice, 2nd edn. Oxford University Press, New York, pp 19–45

    Google Scholar 

  • Radawski C, Morrato E, Hornbuckle K, Bahri P, Smith M, Juhaeri J et al (2015) Benefit-Risk Assessment, Communication, and Evaluation (BRACE) throughout the life cycle of therapeutic products: overall perspective and role of the pharmacoepidemiologist. Pharmacoepidemiol Drug Saf 24(12):1233–1240

    Article  PubMed  Google Scholar 

  • Ramsey AT, Proctor EK, Chambers DA, Garbutt JM, Malone S, Powderly WG et al (2019) Designing for Accelerated Translation (DART) of emerging innovations in health. J Clin Transl Sci 3(2–3):53–58

    Article  PubMed  PubMed Central  Google Scholar 

  • Reed JE, McNicholas C, Woodcock T, Issen L, Bell D (2014) Designing quality improvement initiatives: the action effect method, a structured approach to identifying and articulating programme theory. BMJ Qual Saf 23(12):1040–1048

    Article  PubMed  Google Scholar 

  • Ritzwoller DP, Sukhanova A, Gaglio B, Glasgow RE (2009) Costing behavioral interventions: a practical guide to enhance translation. Ann Behav Med 37(2):218–227

    Article  PubMed  Google Scholar 

  • Rosstad T, Garasen H, Steinsbekk A, Haland E, Kristoffersen L, Grimsmo A (2015) Implementing a care pathway for elderly patients, a comparative qualitative process evaluation in primary care. BMC Health Serv Res 15:86

    Article  PubMed  PubMed Central  Google Scholar 

  • Shelton RC, Cooper BR, Stirman SW (2018) The sustainability of evidence-based interventions and practices in public health and health care. Annu Rev Public Health 39:55–76

    Article  PubMed  Google Scholar 

  • Smith MY, Raynor DKT. Improving the effectiveness of drug safety measures in the EU: the public hearing on valproate. BMC Health Serv Res (in press)

    Google Scholar 

  • Smith MY, Morrato EH (2014) Advancing the field of pharmaceutical risk minimization through application of implementation science best practices. Drug Saf 37(8):569–580

    Article  PubMed  PubMed Central  Google Scholar 

  • Smith ZR, Makowski CT, MacDonald NC (2017) Inpatient pharmacy experience with an audit for a risk evaluation and mitigation strategy for riociguat. Am J Health Syst Pharm 74(21):1762–1763

    Article  PubMed  Google Scholar 

  • Smith MY, Russell A, Bahri P, Mol PGM, Frise S, Freeman E et al (2018) The RIMES Statement: a checklist to assess the quality of studies evaluating risk minimization programs for medicinal products. Drug Saf 41(4):389–401

    Article  PubMed  Google Scholar 

  • Tabak RG, Khoong EC, Chambers DA, Brownson RC (2012) Bridging research and practice: models for dissemination and implementation research. Am J Prev Med 43(3):337–350

    Article  PubMed  PubMed Central  Google Scholar 

  • Tkachenko E, Singer S, Sharma P, Barbieri J, Mostaghimi A (2019) US food and drug administration reports of pregnancy and pregnancy-related adverse events associated with isotretinoin. JAMA Dermatol

    Google Scholar 

  • Trevena LJ, Zikmund-Fisher BJ, Edwards A, Gaissmaier W, Galesic M, Han PKJ et al (2013) Presenting quantitative information about decision outcomes: a risk communication primer for patient decision aid developers. BMC Med Inform Decis Mak 13(S2)

    Google Scholar 

  • Westfall JM, Zittleman L, Felzien M, Norman N, Tamez M, Backlund-Jarquin P et al (2016) Reinventing the wheel of medical evidence: how the boot camp translation process is making gains. Health Aff (Millwood) 35(4):613–618

    Article  Google Scholar 

  • Willy ME, Graham DJ, Racoosin JA, Gill R, Kropp GF, Young J et al (2014) Candidate metrics for evaluating the impact of prescriber education on the safe use of extended-release/long-acting (ER/LA) opioid analgesics. Pain Med 15(9):1558–1568

    Article  PubMed  Google Scholar 

  • Wiltsey Stirman S, Baumann AA, Miller CJ (2019) The FRAME: an expanded framework for reporting adaptations and modifications to evidence-based interventions. Implement Sci 14(1):58

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Parkinson School of Health Sciences and Public Health, Loyola University Chicago, Chicago, IL, USA

    Elaine H. Morrato

  2. Colorado School of Public Health, University of Colorado Anschutz Medical Campus, Aurora, CO, USA

    Elaine H. Morrato

  3. Alexion Pharmaceuticals, Inc., Boston, MA, USA

    Meredith Y. Smith

  4. School of Pharmacy, University of Southern California, Los Angeles, CA, USA

    Meredith Y. Smith

Authors
  1. Elaine H. Morrato
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Meredith Y. Smith
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Elaine H. Morrato .

Editor information

Editors and Affiliations

  1. European Medicines Agency (EMA), Amsterdam, Noord-Holland, The Netherlands

    Priya Bahri

Rights and permissions

Reprints and permissions

Copyright information

© 2020 Springer Nature Singapore Pte Ltd.

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Morrato, E.H., Smith, M.Y. (2020). Dissemination and Implementation Science. In: Bahri, P. (eds) Communicating about Risks and Safe Use of Medicines. Adis, Singapore. https://doi.org/10.1007/978-981-15-3013-5_13

Download citation

  • DOI: https://doi.org/10.1007/978-981-15-3013-5_13

  • Published:

  • Publisher Name: Adis, Singapore

  • Print ISBN: 978-981-15-3012-8

  • Online ISBN: 978-981-15-3013-5

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation